Recent advances in locoregional therapy of hepatocellular carcinoma

A Podlasek, M Abdulla, D Broering, K Bzeizi - Cancers, 2023 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is the fifth most common cancer
worldwide and the second most common oncological reason for death. Liver resection and …

Radiofrequency ablation for hepatocellular carcinoma

H Nishikawa, T Kimura, R Kita… - International Journal of …, 2013 - Taylor & Francis
Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related
mortality worldwide. Unfortunately, only 20% of HCC patients are amenable to curative …

Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic …

G Laimer, P Schullian, N Jaschke, D Putzer, G Eberle… - European …, 2020 - Springer
Objectives To assess the minimal ablative margin (MAM) by image fusion of intraprocedural
pre-and post-ablation contrast-enhanced CT images and to evaluate if it can predict local …

Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience

W Yue, S Wang, S Yu, B Wang - International Journal of …, 2014 - Taylor & Francis
Purpose: The aim of this study was to evaluate the feasibility, safety and efficacy of
ultrasound-guided percutaneous microwave (MW) ablation for solitary T1N0M0 papillary …

Interim efficacy and safety of PD-1 inhibitors in preventing recurrence of hepatocellular carcinoma after interventional therapy

W Qiao, Q Wang, C Hu, Y Zhang, J Li, Y Sun… - Frontiers in …, 2022 - frontiersin.org
Introduction Locoregional interventional therapy including transcatheter arterial
chemoembolization (TACE) and ablation are the current standard of treatment for early-to …

[HTML][HTML] Treatment for hepatocellular carcinoma in elderly patients: a literature review

H Nishikawa, T Kimura, R Kita, Y Osaki - Journal of Cancer, 2013 - ncbi.nlm.nih.gov
An aging society means that the number of elderly patients with cancer is predicted to rise in
the future. Hepatocellular carcinoma (HCC) usually develops in patients with hepatitis B …

Imaging modalities for assessment of treatment response to nonsurgical hepatocellular carcinoma therapy: contrast-enhanced US, CT, and MRI

Y Minami, M Kudo - Liver cancer, 2015 - karger.com
Tumor response and time to progression have been considered pivotal for surrogate
assessment of treatment efficacy for patients with hepatocellular carcinoma (HCC). Recent …

Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours

J Yu, P Liang, X Yu, Z Cheng, Z Han, M Mu, Q Li… - European radiology, 2015 - Springer
Objectives To identify the incidence and risk factors that predict local tumour progression
(LTP) after ultrasound-guided percutaneous microwave ablation (MWA) of liver …

[HTML][HTML] Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI

Y Minami, N Nishida, M Kudo - World Journal of Gastroenterology …, 2014 - ncbi.nlm.nih.gov
Radiofrequency ablation (RFA) is commonly applied for the treatment of hepatocellular
carcinoma (HCC) because of the facile procedure, and the safety and effectiveness for the …

Safety margin after radiofrequency ablation of hepatocellular carcinoma: precise assessment with a three-dimensional reconstruction technique using CT imaging

C Jiang, B Liu, S Chen, Z Peng, X Xie… - International Journal of …, 2018 - Taylor & Francis
Purpose: To analyse the precise ablative margin (AM) after radiofrequency ablation (RFA)
for hepatocellular carcinoma (HCC) and the correlation between AM and local tumour …